Dissecting mechanisms of pioneer transcription factor-mediated lineage reprogramming
Dissecting mechanisms of pioneer transcription factor-mediated lineage reprogramming
批准号:
9427620
负责人:
Samantha Annette Morris
金额:
$32.03万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2017
资助国家:
美国
项目状态:
已结题
起止时间:
2017-09-15 至 2022-08-31
关键词:
BehaviorBindingBinding SitesBiological AssayBypassCell Differentiation processCell LineageCellsChIP-seqChromatinCollaborationsCompetenceComputer AnalysisDataDevelopmentDiseaseEmbryoEndodermEnhancersEventFamilyFibroblastsGenerationsGenesGenetic TranscriptionGenomeGenomicsGoalsHNF4A geneIndividualIntestinesKnowledgeLeadLiverMapsMasksMeasuresMediatingMethodologyMethodsModelingMusNatureOutcomePatternPlayPopulationProcessProductionPropertyProtocols documentationRecording of previous eventsRegenerative MedicineRegulator GenesReportingResolutionRoleSkinSpecific qualifier valueSpeedStem cellsTechnologyTherapeuticTimeTissuesTransposaseWorkbasecell typecellular engineeringcofactordigitalepigenomicsgenome-wideimprovedinnovationnovelpopulation basedprogenitorprogramspromoterstem cell biologytranscription factortranscriptometranscriptome sequencingtranscriptomics
中文摘要
点击翻译按钮获取中文摘要
英文摘要
PROJECT SUMMARY/ABSTRACT
The reprogramming of abundant and accessible cells into therapeutically useful cell types holds great promise
for regenerative medicine. Cellular reprogramming can be achieved by ectopically expressing transcription
factors (TFs) that directly convert one differentiated cell type into another, bypassing embryonic states in an
attempt to boost the speed and efficiency of target cell production. A number of different cell types have been
generated by such “direct lineage reprogramming” methods, but their practical utility has been limited because,
in most protocols, only a small percentage of cells are successfully converted to the target cell type. Even then,
the resulting populations are often partially differentiated or incompletely specified. Most cell engineering
methods require the use of at least one pioneer factor, a unique class of TFs that are able to access their
binding sites in silent chromatin. Pioneer TFs have the capacity to impart lineage competence in a context-
specific manner, and play central roles in development, as reflected by their redeployment across disparate
developmental programs. Our long-term goal is to understand the mechanism of pioneer factor-mediated direct
lineage reprogramming. In this proposal we employ prototypical pioneer TFs, the FoxA family, to drive
conversion of fibroblasts to an endoderm progenitor-like (iEP) state, representing a paradigm for direct lineage
reprogramming. Based on our preliminary results and current evidence, we hypothesize that during direct
lineage reprogramming, pioneer TFs re-engage developmental GRNs, depending on the chromatin state of the
cells into which they are introduced. Our three independent yet related aims are directed at understanding:
(Aim 1) the nature of transcriptional changes during reprogramming from their origin and their relation to
developmental programs; (Aim 2) the direct targets of FoxA pioneer TFs and their cofactor, Hnf4a and their
activity to drive fate change; (Aim 3) the influence of chromatin context on target accessibility of pioneer TFs
and how this impacts efficiency of reprogramming and the potential of cells generated. Here we apply an
innovative single-cell lineage tracing methodology and genomic technology to record TF binding history in cells
undergoing reprogramming. Together, this will generate an unprecedented digital quantification of the
reprogramming process, and will reveal barriers to the successful conversion of cell identity. An improved
understanding of pioneer-mediated reprogramming mechanisms will facilitate enhanced conversion efficiency
and fidelity across an array of reprogramming strategies, and improve knowledge of the action of this important
class of transcriptional regulators.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Tracing the origin of regenerative and scarring fibroblasts during wound healing with single-cell technologies
-
批准号:10216730
-
项目类别:
-
资助金额:$39.41万
-
财政年份:2021
-
负责人:Samantha Annette Morris
-
依托单位:
Dissecting mechanisms of pioneer transcription factor-mediated lineage reprogramming
-
批准号:10245180
-
项目类别:
-
资助金额:$32.03万
-
财政年份:2017
-
负责人:Samantha Annette Morris
-
依托单位:
国内基金
海外基金
登录
查看更多内容
帽结合蛋白(cap binding protein)调控乙烯信号转导的分子机制
-
批准号:32170319
-
项目类别:面上项目
-
资助金额:58.00万元
-
批准年份:2021
-
负责人:董春海
-
依托单位:
帽结合蛋白(cap binding protein)调控乙烯信号转导的分子机制
-
批准号:--
-
项目类别:--
-
资助金额:58万元
-
批准年份:2021
-
负责人:董春海
-
依托单位:
ID1 (Inhibitor of DNA binding 1) 在口蹄疫病毒感染中作用机制的研究
-
批准号:31672538
-
项目类别:面上项目
-
资助金额:62.0万元
-
批准年份:2016
-
负责人:孙跃峰
-
依托单位:
番茄EIN3-binding F-box蛋白2超表达诱导单性结实和果实成熟异常的机制研究
-
批准号:31372080
-
项目类别:面上项目
-
资助金额:80.0万元
-
批准年份:2013
-
负责人:杨迎伍
-
依托单位:
P53 binding protein 1 调控乳腺癌进展转移及化疗敏感性的机制研究
-
批准号:81172529
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2011
-
负责人:杨其峰
-
依托单位:
DBP(Vitamin D Binding Protein)在多发性硬化中的作用和相关机制的蛋白质组学研究
-
批准号:81070952
-
项目类别:面上项目
-
资助金额:35.0万元
-
批准年份:2010
-
负责人:刘师莲
-
依托单位:
研究EB1(End-Binding protein 1)的癌基因特性及作用机制
-
批准号:30672361
-
项目类别:面上项目
-
资助金额:24.0万元
-
批准年份:2006
-
负责人:徐宁志
-
依托单位: